STERIS plc (Ireland) Ordinary Shares (STE) Company Bio
Steris Corporation develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The company was founded in 1985 and is based in Mentor, Ohio.
STE Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for STERIS plc. To summarize, we found that STERIS plc ranked in the 39th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 27.5%. In terms of the factors that were most noteworthy in this DCF analysis for STE, they are:
The company's debt burden, as measured by earnings divided by interest payments, is 13.87; that's higher than 77.47% of US stocks in the Healthcare sector that have positive free cash flow.
The business' balance sheet suggests that 7% of the company's capital is sourced from debt; this is greater than just 18.27% of the free cash flow producing stocks we're observing.
STE's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 40.92% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
ICLR, EBS, CNC, PAHC, and BDX can be thought of as valuation peers to STE, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
DUBLIN, IRELAND, July 22, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 first quarter financial results at 10:00 a.m. Eastern Time on Tuesday, August 4, 2020. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing first quarter financial results will be issued after the U.S. market closes on Monday, August 3, 2020. For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. Eastern Time on August 4, 2020, either over the Internet at ww...